1. Home
  2. Labeler Index
  3. Fresenius Kabi Usa Llc
  4. 65219-276
  5. NDC Package Code: 65219-276-10 Succinylcholine Chloride

NDC Package 65219-276-10 Succinylcholine Chloride

Injection, Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
65219-276-10
Package Description:
10 SYRINGE, PLASTIC in 1 CARTON / 10 mL in 1 SYRINGE, PLASTIC (65219-276-01)
Product Code:
65219-276
Proprietary Name:
Succinylcholine Chloride
Non-Proprietary Name:
Succinylcholine Chloride
Substance Name:
Succinylcholine Chloride Dihydrate
Usage Information:
Succinylcholine chloride injection is indicated in adults and pediatric patients: as an adjunct to general anesthesia to facilitate tracheal intubation to provide skeletal muscle relaxation during surgery or mechanical ventilation
11-Digit NDC Billing Format:
65219027610
NDC to RxNorm Crosswalk:
  • RxCUI: 2694114 - succinylcholine chloride 200 MG in 10 ML Prefilled Syringe
  • RxCUI: 2694114 - 10 ML succinylcholine chloride 20 MG/ML Prefilled Syringe
  • RxCUI: 2694114 - succinylcholine chloride 200 MG per 10 ML Prefilled Syringe
Product Type:
Human Prescription Drug
Labeler Name:
Fresenius Kabi Usa Llc
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
SUCCINYLCHOLINE CHLORIDE DIHYDRATE 20 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA217885
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
06-19-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 65219-276-10?

The NDC Packaged Code 65219-276-10 is assigned to a package of 10 syringe, plastic in 1 carton / 10 ml in 1 syringe, plastic (65219-276-01) of Succinylcholine Chloride, a human prescription drug labeled by Fresenius Kabi Usa Llc. The product's dosage form is injection, solution and is administered via intramuscular; intravenous form.

Is NDC 65219-276 included in the NDC Directory?

Yes, Succinylcholine Chloride with product code 65219-276 is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Usa Llc on June 19, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 65219-276-10?

The 11-digit format is 65219027610. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-265219-276-105-4-265219-0276-10